Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 162

Similar articles for PubMed (Select 19339358)

1.

Can phase III trial results of antidepressant medications be generalized to clinical practice? A STAR*D report.

Wisniewski SR, Rush AJ, Nierenberg AA, Gaynes BN, Warden D, Luther JF, McGrath PJ, Lavori PW, Thase ME, Fava M, Trivedi MH.

Am J Psychiatry. 2009 May;166(5):599-607. doi: 10.1176/appi.ajp.2008.08071027. Epub 2009 Apr 1.

PMID:
19339358
2.

Does the duration of index episode affect the treatment outcome of major depressive disorder? A STAR*D report.

Gilmer WS, Gollan JK, Wisniewski SR, Howland RH, Trivedi MH, Miyahara S, Fleck J, Thase ME, Alpert JE, Nierenberg AA, Warden D, Fava M, Rush AJ.

J Clin Psychiatry. 2008 Aug;69(8):1246-56.

PMID:
18681756
3.

Sociodemographic, clinical, and treatment characteristics associated with worsened depression during treatment with citalopram: results of the NIMH STAR(*)D trial.

Friedman ES, Wisniewski SR, Gilmer W, Nierenberg AA, Rush AJ, Fava M, Zisook S, Balasubramani GK, Trivedi MH.

Depress Anxiety. 2009;26(7):612-21. doi: 10.1002/da.20568.

PMID:
19382183
4.

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.

Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M; STAR*D Study Team.

Am J Psychiatry. 2006 Jan;163(1):28-40.

PMID:
16390886
5.

Do atypical features affect outcome in depressed outpatients treated with citalopram?

Stewart JW, McGrath PJ, Fava M, Wisniewski SR, Zisook S, Cook I, Nierenberg AA, Trivedi MH, Balasubramani GK, Warden D, Lesser I, John Rush A.

Int J Neuropsychopharmacol. 2010 Feb;13(1):15-30. doi: 10.1017/S1461145709000182. Epub 2009 Apr 3.

PMID:
19341509
6.

Income and attrition in the treatment of depression: a STAR*D report.

Warden D, Rush AJ, Wisniewski SR, Lesser IM, Thase ME, Balasubramani GK, Shores-Wilson K, Nierenberg AA, Trivedi MH.

Depress Anxiety. 2009;26(7):622-33. doi: 10.1002/da.20541.

PMID:
19582825
7.

Does comorbid substance use disorder impair recovery from major depression with SSRI treatment? An analysis of the STAR*D level one treatment outcomes.

Davis LL, Wisniewski SR, Howland RH, Trivedi MH, Husain MM, Fava M, McGrath PJ, Balasubramani GK, Warden D, Rush AJ.

Drug Alcohol Depend. 2010 Mar 1;107(2-3):161-70. doi: 10.1016/j.drugalcdep.2009.10.003. Epub 2009 Nov 28.

PMID:
19945804
8.

Clinical correlates of the worsening or emergence of suicidal ideation during SSRI treatment of depression: an examination of citalopram in the STAR*D study.

Zisook S, Trivedi MH, Warden D, Lebowitz B, Thase ME, Stewart JW, Moutier C, Fava M, Wisniewski SR, Luther J, Rush AJ.

J Affect Disord. 2009 Sep;117(1-2):63-73. doi: 10.1016/j.jad.2009.01.002. Epub 2009 Feb 14.

PMID:
19217668
9.

Treatment outcomes for older depressed patients with earlier versus late onset of first depressive episode: a Sequenced Treatment Alternatives to Relieve Depression (STAR*D) report.

Kozel FA, Trivedi MH, Wisniewski SR, Miyahara S, Husain MM, Fava M, Lebowitz B, Zisook S, Rush AJ.

Am J Geriatr Psychiatry. 2008 Jan;16(1):58-64. doi: 10.1097/JGP.0b013e31815a43d7.

PMID:
18165462
10.

Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report.

Warden D, Trivedi MH, Wisniewski SR, Davis L, Nierenberg AA, Gaynes BN, Zisook S, Hollon SD, Balasubramani GK, Howland R, Fava M, Stewart JW, Rush AJ.

Am J Psychiatry. 2007 Aug;164(8):1189-97.

PMID:
17671281
11.

Family history of depression and therapeutic outcome: findings from STAR*D.

Husain MM, Rush AJ, Wisniewski SR, McClintock SM, Fava M, Nierenberg AA, Davis L, Balasubramani GK, Young E, Albala AA, Trivedi MH.

J Clin Psychiatry. 2009 Feb;70(2):185-95. Epub 2008 Dec 2.

PMID:
19192454
12.

Acceptability of second-step treatments to depressed outpatients: a STAR*D report.

Wisniewski SR, Fava M, Trivedi MH, Thase ME, Warden D, Niederehe G, Friedman ES, Biggs MM, Sackeim HA, Shores-Wilson K, McGrath PJ, Lavori PW, Miyahara S, Rush AJ.

Am J Psychiatry. 2007 May;164(5):753-60.

PMID:
17475734
13.

Ethnicity/race and outcome in the treatment of depression: results from STAR*D.

Lesser IM, Castro DB, Gaynes BN, Gonzalez J, Rush AJ, Alpert JE, Trivedi M, Luther JF, Wisniewski SR.

Med Care. 2007 Nov;45(11):1043-51.

PMID:
18049344
14.

A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.

Fava M, Rush AJ, Wisniewski SR, Nierenberg AA, Alpert JE, McGrath PJ, Thase ME, Warden D, Biggs M, Luther JF, Niederehe G, Ritz L, Trivedi MH.

Am J Psychiatry. 2006 Jul;163(7):1161-72.

PMID:
16816220
15.

Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.

Howland RH, Rush AJ, Wisniewski SR, Trivedi MH, Warden D, Fava M, Davis LL, Balasubramani GK, McGrath PJ, Berman SR.

Drug Alcohol Depend. 2009 Jan 1;99(1-3):248-60. doi: 10.1016/j.drugalcdep.2008.08.010. Epub 2008 Nov 5.

PMID:
18986774
16.
17.

Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features.

Rush AJ, Wisniewski SR, Warden D, Luther JF, Davis LL, Fava M, Nierenberg AA, Trivedi MH.

Arch Gen Psychiatry. 2008 Aug;65(8):870-80. doi: 10.1001/archpsyc.65.8.870.

PMID:
18678792
18.

Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report.

McGrath PJ, Khan AY, Trivedi MH, Stewart JW, Morris DW, Wisniewski SR, Miyahara S, Nierenberg AA, Fava M, Rush AJ.

J Clin Psychiatry. 2008 Dec;69(12):1847-55. Epub 2008 Nov 18.

PMID:
19026268
19.

Diurnal mood variation in outpatients with major depressive disorder.

Morris DW, Trivedi MH, Fava M, Wisniewski SR, Balasubramani GK, Khan AY, Jain S, Rush AJ.

Depress Anxiety. 2009;26(9):851-63. doi: 10.1002/da.20557.

PMID:
19306304
20.

Are subjects in pharmacological treatment trials of depression representative of patients in routine clinical practice?

Zimmerman M, Mattia JI, Posternak MA.

Am J Psychiatry. 2002 Mar;159(3):469-73.

PMID:
11870014
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk